Drawing on the experience of exploring global AI pharmaceutical platforms,we can open up the data barriers of innovative drugs by creating a high-quality biological big data based on preclinical and clinical data,which will help domestic pharmaceutical enterprises to catch up with or even surpass the long-term data accumulation of multinational pharmaceutical enterprises in the short term,change the trend of follower innovation and safe but ineffective drugs,and find the path of future bio-economic development by combining"wet and dry",and guide them to carry out high-quality innovation research with the direction of data as the gripping hand and innovation curation as the orientation.
关键词
AI制药/计算生物学/生物医药/大数据平台
Key words
AI pharmaceuticals/Computational biology/Biopharmaceuticals/Big data platform
维普
万方数据